Familial glucocorticoid deficiency due to a novel TXNRD2 variant: expanding the spectrum of a rare genetic cause - Report - MDSpire

Familial glucocorticoid deficiency due to a novel TXNRD2 variant: expanding the spectrum of a rare genetic cause

  • By

  • Ibrahim Al Alwan

  • Kheloud M. Alhamoudi

  • Abdullah Ibrahim Alzaben

  • Beshaier Almulhem

  • Nawal Qawasmi

  • Meshael Alswailem

  • Sara Alotaibi

  • Burair Alsaihati

  • Amjad Jabaan

  • Moeber Mahzari

  • Christa E. Flück

  • Ali S. Alzahrani

  • May 28, 2026

Share

Clinical Report: A Novel TXNRD2 Variant Linked to Familial Glucocorticoid Deficiency

Overview

This report identifies a novel homozygous TXNRD2 variant associated with familial glucocorticoid deficiency (FGD) in a Saudi patient. The findings expand the genetic understanding of FGD and highlight the role of mitochondrial dysfunction in adrenal insufficiency.

Background

Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by cortisol deficiency and elevated ACTH levels. Recent advances in genetics have revealed that FGD is a genetically heterogeneous condition, with various genes implicated in its pathogenesis. Understanding the genetic basis of FGD is crucial for accurate diagnosis and management of affected individuals.

Data Highlights

VariantTypeFrequencyEffect
c.575C>T (p.Pro192Leu)Homozygous0.00000479Likely pathogenic

Key Findings

  • A novel homozygous TXNRD2 variant (c.575C>T) was identified in a patient with FGD.
  • The variant was not found in a local population database of over 18,000 exomes.
  • Segregation analysis confirmed autosomal recessive inheritance.
  • The variant affects a highly conserved amino acid and is predicted to be deleterious.
  • No other pathogenic variants were found in known FGD-associated genes.

Clinical Implications

Clinicians should consider genetic testing for TXNRD2 variants in patients presenting with symptoms of adrenal insufficiency, particularly in cases of familial glucocorticoid deficiency. Early identification of such variants can inform management strategies and genetic counseling for affected families.

Conclusion

The identification of this novel TXNRD2 variant enhances the understanding of the genetic landscape of familial glucocorticoid deficiency and underscores the importance of mitochondrial function in adrenal health.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Case report and literature review: novel TXNRD2 compound heterozygous variants in familial glucocorticoid deficiency type 5 - PMC
  6. Adrenal insufficiency: identification and management - NCBI Bookshelf
  7. Familial glucocorticoid deficiency and TXNRD2
  8. Adrenal insufficiency: identification and management - NCBI Bookshelf

Original Source(s)

Related Content